No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
H.C. Wainwright Maintains Century Therapeutics(IPSC.US) With Buy Rating, Maintains Target Price $2
William Blair Maintains Century Therapeutics(IPSC.US) With Hold Rating
Piper Sandler Maintains Century Therapeutics(IPSC.US) With Buy Rating, Maintains Target Price $2
Piper Sandler Remains a Buy on Century Therapeutics (IPSC)
Century Therapeutics (IPSC) Gets a Hold From William Blair
Scion Life Sciences Expands Team With Appointment of Three Venture Partners